Patrick T Mooney

Title: The Innovations of Patrick T. Mooney

Introduction

Patrick T. Mooney is a notable inventor based in Haddonfield, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that modulate estrogen receptor activity. With a total of 2 patents, his work is paving the way for advancements in treating various disease states and conditions.

Latest Patents

One of Patrick's latest patents is focused on an enantiomerically purified GPER agonist for use in treating disease states and conditions. This patent provides a detailed disclosure of 1) an enantiomerically purified compound SRR G-1, or a derivative thereof, including specific crystal forms, salts, and co-crystals that modulate G protein-coupled estrogen receptor activity. It also includes 2) pharmaceutical and cosmetic compositions comprising the enantiomerically purified SRR G-1, or a derivative thereof, and 3) methods of treating or preventing disease states and conditions and cosmetic conditions mediated through these receptors and related methods in humans and animals.

Career Highlights

Patrick T. Mooney is currently associated with Linnaeus Therapeutics, Inc., where he continues to innovate and develop new therapeutic solutions. His work is characterized by a strong focus on the intersection of pharmaceutical science and practical applications in healthcare.

Collaborations

Throughout his career, Patrick has collaborated with talented individuals such as Christopher Natale and Tina Garyantes. These collaborations have contributed to the success of his projects and the advancement of their shared goals in the field of therapeutics.

Conclusion

Patrick T. Mooney's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of treatments for various medical conditions, showcasing the importance of innovation in healthcare.